Provided herein are novel pyridazine compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such compounds in treating Parkinson's disease or frontotemporal dementia, and processes for preparing such compounds.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11647718 | PMC |
http://dx.doi.org/10.1021/acsmedchemlett.4c00523 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!